CASC

Cascadian Therapeutics, Inc.
CASC

Overview Fund Activity
Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

93 hedge funds and large institutions have $155M invested in Cascadian Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 43 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-7
Holders Change %
-7%
% of All Funds
2.6%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
13
Increased
21
Reduced
43
Closed
18
Calls
$890K
Puts
$296K
Net Calls
+$594K
Net Calls Change
-$661K

Top Buyers

1
BI
1
BVF Inc
California
$44.8M
2
CS
2
Candriam SCA
Luxembourg
$2.87M
3
EC
3
EcoR1 Capital
California
$2.59M
4
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$1.45M
5
State Street
5
State Street
Massachusetts
$4.34M

Top Sellers

1
BC
1
Broadfin Capital
New York
$1.62M
2
ACP
2
Acuta Capital Partners
California
$0
3
Franklin Resources
3
Franklin Resources
California
$18.9M
4
BIT
4
BlackRock Institutional Trust
California
$7.82M
5
RG
5
Redmile Group
California
$9.91M
Name Holding Trade Value Shares
Change 		Shares
Change %
BJ
101
BlackRock Japan
Japan
– -$26K -1,137 Closed
BRWM
102
B. Riley Wealth Management
Tennessee
– -$18K -833 Closed
Walleye Trading
103
Walleye Trading
New York
– -$12K -517 Closed
SFPIA
104
Stevens First Principles Investment Advisors
California
– -$11K -500 Closed
Invesco
105
Invesco
Georgia
– -$5K -235 Closed
Federated Hermes
106
Federated Hermes
Pennsylvania
– -$1K -25 Closed
1 2 3 4
5